Supplemental material
OncoImmunology
Volume 12, 2023 - Issue 1
Open access
1,464
Views
2
CrossRef citations to date
0
Altmetric
Original research
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients
Annalisa Adamoa Immunology section, Department of Medicine University and Hospital Trust of Verona, Verona, ItalyView further author information
, Cristina Frusteria Immunology section, Department of Medicine University and Hospital Trust of Verona, Verona, ItalyView further author information
, Sara Pilottob Oncology section, Department of Engineering for Innovative Medicine and Hospital Trust of Verona, Verona, ItalyCorrespondence[email protected]
View further author information
, View further author information
Simone Caligolac Veneto Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IOV-IRCCS), Padova, ItalyView further author information
, Lorenzo Belluominib Oncology section, Department of Engineering for Innovative Medicine and Hospital Trust of Verona, Verona, ItalyView further author information
, Ornella Poffea Immunology section, Department of Medicine University and Hospital Trust of Verona, Verona, ItalyView further author information
, Luca Giacobazzia Immunology section, Department of Medicine University and Hospital Trust of Verona, Verona, ItalyView further author information
, Silvia Dusic Veneto Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IOV-IRCCS), Padova, ItalyView further author information
, Chiara Musiua Immunology section, Department of Medicine University and Hospital Trust of Verona, Verona, ItalyView further author information
, Yushu Hua Immunology section, Department of Medicine University and Hospital Trust of Verona, Verona, ItalyView further author information
, Tian Wanga Immunology section, Department of Medicine University and Hospital Trust of Verona, Verona, ItalyView further author information
, Davide Rizzinia Immunology section, Department of Medicine University and Hospital Trust of Verona, Verona, ItalyView further author information
, Antonio Vellaa Immunology section, Department of Medicine University and Hospital Trust of Verona, Verona, ItalyView further author information
, Stefania Canèc Veneto Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IOV-IRCCS), Padova, ItalyView further author information
, Giulia Sartorib Oncology section, Department of Engineering for Innovative Medicine and Hospital Trust of Verona, Verona, ItalyView further author information
, Jessica Insoldab Oncology section, Department of Engineering for Innovative Medicine and Hospital Trust of Verona, Verona, ItalyView further author information
, Marco Spositob Oncology section, Department of Engineering for Innovative Medicine and Hospital Trust of Verona, Verona, ItalyView further author information
, Ursula Cesta Incanib Oncology section, Department of Engineering for Innovative Medicine and Hospital Trust of Verona, Verona, ItalyView further author information
, Carmine Carboned Medical Oncology, Department of Medical and Surgical Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, ItalyView further author information
, Geny Pirod Medical Oncology, Department of Medical and Surgical Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, ItalyView further author information
, Francesca Pettinellae General Pathology section, Department of Medicine University of Verona, Verona, ItalyView further author information
, Fang Qif Department of Burns and Plastic Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, P.R. ChinaView further author information
, Dali Wangf Department of Burns and Plastic Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, P.R. ChinaView further author information
, Silvia Sartorisa Immunology section, Department of Medicine University and Hospital Trust of Verona, Verona, ItalyView further author information
, Francesco De Sanctisa Immunology section, Department of Medicine University and Hospital Trust of Verona, Verona, ItalyView further author information
, Patrizia Scapinie General Pathology section, Department of Medicine University of Verona, Verona, ItalyView further author information
, Stefano Dusie General Pathology section, Department of Medicine University of Verona, Verona, ItalyView further author information
, Marco Antonio Cassatellae General Pathology section, Department of Medicine University of Verona, Verona, ItalyView further author information
, Emilio Briac Veneto Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IOV-IRCCS), Padova, ItalyView further author information
, Michele Milellab Oncology section, Department of Engineering for Innovative Medicine and Hospital Trust of Verona, Verona, ItalyView further author information
, Vincenzo Brontec Veneto Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IOV-IRCCS), Padova, ItalyView further author information
& Stefano Ugela Immunology section, Department of Medicine University and Hospital Trust of Verona, Verona, ItalyCorrespondence[email protected]
https://orcid.org/0000-0002-6639-7608View further author information
show allhttps://orcid.org/0000-0002-6639-7608View further author information
Article: 2253644
|
Received 10 Mar 2023, Accepted 26 Aug 2023, Published online: 14 Sep 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.